Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
Titel:
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
Auteur:
Smyth, L. M. Iyengar, N. M. Chen, M. F. Popper, S. M. Patil, S. Wasserheit-Lieblich, C. Argolo, D. F. Singh, J. C. Chandarlapaty, S. Sugarman, S. M. Comen, E. A. Drullinsky, P. R. Traina, T. A. Troso-Sandoval, T. Baselga, J. Norton, L. Hudis, C. A. Dang, C. T.